Clinical Trial Update: Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating safety and immunogenicity of a Hepatitis A vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Vaccination | Phase 4 | Status: UNKNOWN